A bio-data company accelerating next-gen therapeutics
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Waltham
State: Massachusetts
Zip:
Country: United States
Gatehouse Bio is a biotechnology company focused on advancing precision medicine to accelerate the development of next-gen therapeutics. Their technology is based on a patented, revolutionary approach to uncover small RNA (sRNA) signatures of disease using biology influenced machine learning. sRNA signatures provide a platform for drug discovery and drug repurposing, and have been validated in cardiology, neurology, oncology, respiratory and rare diseases by industry leaders and the FDA. They have unique business model that promotes collaboration with leading drug developers to identify novel drug targets and discover companion diagnostics.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Series A | 2 | $5.4M |
IndieBio SOSV IndieBio SOSV |
9/2022 | Seed Round | 2 | - |
SOSV IndieBio SOSV IndieBio |
1/2021 | Seed Round | $0 |
Front Row Fund Front Row Fund |
6/2022 | Convertible Note | 2 | - |
IndieBio SOSV IndieBio SOSV |
12/2021 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
12/2020 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
6/2022 | Convertible Note | 2 | - |
IndieBio SOSV IndieBio SOSV |
12/2021 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
1/2021 | Seed Round | 1 | $2.5M |
Front Row Fund Front Row Fund |
12/2020 | Seed Round | 2 | - |
IndieBio SOSV IndieBio SOSV |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|